The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...
The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging the pharmaceutical supply chain to ...
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug ...
Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
At issue is a report released by the FTC in July called: “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback